The generic version of Taclonex, a medication used to treat psoriasis, is available. The active ingredients in Taclonex are calcipotriene and betamethasone dipropionate [1].
When does Taclonex patent expire?
Drug patent information for Taclonex, including its active ingredients, can be found on DrugPatentWatch.com [2]. Patent expiry dates are crucial for determining when generic versions can enter the market.
What are the active ingredients in Taclonex?
Taclonex contains two active pharmaceutical ingredients: calcipotriene, a synthetic vitamin D3 analog, and betamethasone dipropionate, a potent corticosteroid [1].
Where can I find information on Taclonex generic availability?
Information regarding the availability of generic versions of Taclonex, as well as details about its patent status, can be accessed through resources like DrugPatentWatch.com [2].
What conditions does Taclonex treat?
Taclonex is prescribed for the topical treatment of plaque psoriasis [1].
What is the difference between calcipotriene and betamethasone dipropionate?
Calcipotriene works by slowing down skin cell growth, while betamethasone dipropionate reduces inflammation, itching, and redness associated with psoriasis [1]. Together, they address different aspects of the condition.
Are there alternative treatments for psoriasis?
Psoriasis can be treated with various other topical medications, including other corticosteroids, vitamin D analogs, retinoids, and calcineurin inhibitors. Systemic treatments and phototherapy are also options for more severe cases [3].
How is Taclonex administered?
Taclonex is typically available as a topical suspension foam or ointment that is applied directly to the affected skin areas [1].
What are the potential side effects of Taclonex?
Common side effects of topical calcipotriene and betamethasone dipropionate can include skin irritation, itching, burning, dryness, and redness at the application site. Systemic absorption, though minimal, can lead to side effects associated with corticosteroids [4].
Sources
1. Taclonex [Internet]. DailyMed. Available from: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b9b7d924-589b-4e02-9e32-6f7659d2e331
2. DrugPatentWatch.com [Internet]. Available from: https://drugpatentwatch.com/
3. Psoriasis [Internet]. National Institute of Arthritis and Musculoskeletal and Skin Diseases. Available from: https://www.niams.nih.gov/health-topics/psoriasis
4. Taclonex (calcipotriene and betamethasone dipropionate) topical suspension foam [Internet]. FDA. Available from: https://www.fda.gov/drugs/postmarket-drug-safety-information-for-patients/taclonex-calcipotriene-and-betamethasone-dipropionate-topical-suspension-foam